New and emerging treatments for vitiligo: a narrative review
Expert Review of Clinical Pharmacology · 2026
DOI: 10.1080/17512433.2026.2626458 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2026. Verfasst von Carolina Rodrigues Mendonça und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Vitiligo, Dermatologic Agents, Quality of Life, Pyrazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 109 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Vitiligo is a chronic autoimmune skin disorder characterized by progressive melanocyte loss, resulting in well-demarcated depigmented patches that significantly impact quality of life. Affecting 0.5-2% of the global population, vitiligo poses both psychosocial and therapeutic challenges. Despite multiple conventional therapies such as corticosteroids, calcineurin inhibitors, and phototherapy, durable repigmentation remains difficult to achieve. AREAS COVERED: This review summarizes recent advances in understanding the emerging medical treatment of vitiligo. A targeted literature search was conducted using PubMed, Embase, and ClinicalTrials.gov from inception to April 2025. Key clinical trial data are discussed to evaluate efficacy, safety and durability of response across therapeutic classes. EXPERT OPINION: The approval of topical ruxolitinib marks a pivotal step toward precision therapy in vitiligo. Ongoing studies of combination and maintenance regimens offer promise for sustained repigmentation and disease stabilization. However, optimizing long-term outcomes requires continued translational research to elucidate mechanisms of relapse, improve accessibility of emerging therapies and personalize treatment strategies to individual disease phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
- Temerty Faculty of Medicine, University of Toronto, Toronto, ON , Canada.
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON , Canada.
- Department of Dermatology, Centro Hospitalar Universitário de Sto António, Porto, Portugal.
Zitieren
APA
Mendonça, C. R., Mohamed, A., Mohamed, A., Ferreira, C., & Torres, T. (2026). New and emerging treatments for vitiligo: a narrative review. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2026.2626458
Vancouver
Mendonça CR, Mohamed A, Mohamed A, Ferreira C, Torres T. New and emerging treatments for vitiligo: a narrative review. Expert Review of Clinical Pharmacology. 2026. doi:10.1080/17512433.2026.2626458
BibTeX
@article{Mendona2026,
author = {Mendonça, Carolina Rodrigues and Mohamed, Adam and Mohamed, Amir and Ferreira, Cesar and Torres, Tiago},
title = {New and emerging treatments for vitiligo: a narrative review},
journal = {Expert Review of Clinical Pharmacology},
year = {2026},
doi = {10.1080/17512433.2026.2626458}
}
EUVIMED